{"id":"https://openalex.org/W2015471089","doi":"https://doi.org/10.1016/0959-8049(95)00200-3","title":"Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer","display_name":"Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer","publication_year":1995,"publication_date":"1995-09-01","ids":{"openalex":"https://openalex.org/W2015471089","doi":"https://doi.org/10.1016/0959-8049(95)00200-3","mag":"2015471089","pmid":"https://pubmed.ncbi.nlm.nih.gov/7488410"},"language":"en","primary_location":{"id":"doi:10.1016/0959-8049(95)00200-3","doi":"https://doi.org/10.1016/0959-8049(95)00200-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0959-8049(95)00200-3","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111948408","display_name":"M L\u00f3pez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Lopez","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010531543","display_name":"Patrizia Vici","orcid":"https://orcid.org/0000-0001-7528-9783","observed_orcids":["https://orcid.org/0000-0001-7528-9783"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Vici","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107840765","display_name":"Luigi Di Lauro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"L. Di Lauro","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040571142","display_name":"G Paoletti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Paoletti","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052366144","display_name":"Tommaso Gionfra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"T. Gionfra","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109317818","display_name":"Francesca Conti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Conti","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020845536","display_name":"Silvia Carpano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Carpano","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017364811","display_name":"Francesco Pignatti","orcid":"https://orcid.org/0000-0001-9296-2474","observed_orcids":["https://orcid.org/0000-0001-9296-2474"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Pignatti","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086743021","display_name":"Diana Giannarelli","orcid":"https://orcid.org/0000-0002-6085-1195","observed_orcids":["https://orcid.org/0000-0002-6085-1195"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D. Giannarelli","raw_affiliation_strings":["Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Oncologia Medica II, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Viale Regina Elena, 291,00161 Roma, Italy","institution_ids":["https://openalex.org/I4387152244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4387152244"],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":null,"fwci":0.4772,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.5997761,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"31","issue":"10","first_page":"1611","last_page":"1614"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.4138000011444092,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.4138000011444092,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.38449999690055847,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.05609999969601631,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8370000123977661},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/lonidamine","display_name":"lonidamine","score":0.996999979019165},{"id":"https://openalex.org/keywords/anthracycline-resistance","display_name":"anthracycline resistance","score":0.9959999918937683},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.718999981880188},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.4830000102519989},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.9497127532958984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8602114319801331},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7202700972557068},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6639717817306519},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6487582921981812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6457028388977051},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5654822587966919},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5625370144844055},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5583086609840393},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5403236746788025},{"id":"https://openalex.org/C2779051857","wikidata":"https://www.wikidata.org/wiki/Q911386","display_name":"Stomatitis","level":2,"score":0.4851694703102112},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.47170472145080566},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4323709309101105},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.4238322377204895},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.4185253977775574},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4052935838699341},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3826306462287903},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3551371097564697}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0959-8049(95)00200-3","doi":"https://doi.org/10.1016/0959-8049(95)00200-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0959-8049(95)00200-3","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:7488410","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7488410","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1967221808","https://openalex.org/W1997241897","https://openalex.org/W2008121806","https://openalex.org/W2012431622","https://openalex.org/W2016409260","https://openalex.org/W2017921725","https://openalex.org/W2034419204","https://openalex.org/W2037705779","https://openalex.org/W2059926910","https://openalex.org/W2077834742","https://openalex.org/W2092257274","https://openalex.org/W2099687525","https://openalex.org/W2139330198","https://openalex.org/W2167805334","https://openalex.org/W2183288147","https://openalex.org/W2264155967","https://openalex.org/W2265230738","https://openalex.org/W2305791584","https://openalex.org/W2412595369","https://openalex.org/W2615953705","https://openalex.org/W3141080196","https://openalex.org/W4285719527","https://openalex.org/W4302210509","https://openalex.org/W6715594945"],"related_works":["https://openalex.org/W2229497644","https://openalex.org/W2992566835","https://openalex.org/W2063071819","https://openalex.org/W2022210973","https://openalex.org/W2079540472","https://openalex.org/W2071588876","https://openalex.org/W2099687525","https://openalex.org/W2006350488","https://openalex.org/W2546463064","https://openalex.org/W2164728818"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}